Molecular Templates Statistics
Total Valuation
Molecular Templates has a market cap or net worth of 263,355. The enterprise value is 1.63 million.
| Market Cap | 263,355 |
| Enterprise Value | 1.63M |
Important Dates
The next estimated earnings date is Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Molecular Templates has 6.58 million shares outstanding. The number of shares has increased by 49.22% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 6.58M |
| Shares Change (YoY) | +49.22% |
| Shares Change (QoQ) | -6.54% |
| Owned by Insiders (%) | 3.96% |
| Owned by Institutions (%) | 7.62% |
| Float | 4.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | 0.04 |
| P/TBV Ratio | 0.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.10 |
| EV / Sales | 0.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 1.55.
| Current Ratio | 1.56 |
| Quick Ratio | 1.36 |
| Debt / Equity | 1.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -135.64 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -37.88% |
| Return on Capital (ROIC) | -103.19% |
| Revenue Per Employee | 410,806 |
| Profits Per Employee | -252,032 |
| Employee Count | 62 |
| Asset Turnover | 0.82 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.93% in the last 52 weeks. The beta is 1.08, so Molecular Templates's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -98.93% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 25.22 |
| Average Volume (20 Days) | 14,606,352 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, Molecular Templates had revenue of 25.47 million and -15.63 million in losses. Loss per share was -2.79.
| Revenue | 25.47M |
| Gross Profit | -3.76M |
| Operating Income | -18.85M |
| Pretax Income | -15.64M |
| Net Income | -15.63M |
| EBITDA | -13.87M |
| EBIT | -18.85M |
| Loss Per Share | -2.79 |
Balance Sheet
The company has 9.66 million in cash and 11.03 million in debt, giving a net cash position of -1.37 million or -0.21 per share.
| Cash & Cash Equivalents | 9.66M |
| Total Debt | 11.03M |
| Net Cash | -1.37M |
| Net Cash Per Share | -0.21 |
| Equity (Book Value) | 7.11M |
| Book Value Per Share | 1.08 |
| Working Capital | 4.34M |
Cash Flow
| Operating Cash Flow | -23.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -14.75%, with operating and profit margins of -74.02% and -61.35%.
| Gross Margin | -14.75% |
| Operating Margin | -74.02% |
| Pretax Margin | -61.39% |
| Profit Margin | -61.35% |
| EBITDA Margin | -54.44% |
| EBIT Margin | -74.02% |
| FCF Margin | n/a |
Dividends & Yields
Molecular Templates does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.22% |
| Shareholder Yield | -49.22% |
| Earnings Yield | -6,968.75% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on August 14, 2023. It was a reverse split with a ratio of 0.0666667.
| Last Split Date | Aug 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0666667 |
Scores
Molecular Templates has an Altman Z-Score of -24.59. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -24.59 |
| Piotroski F-Score | n/a |